Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis
Ophthalmology and Therapy · 2024-05 · 13 (5) · 1255-1269
DOI: 10.1007/s40123-024-00915-0 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Ophthalmology and Therapy, online erschienen am 18.03.2024. Verfasst von Jing Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bayer Healthcare Company Ltd., Beijing, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
- Shanghai Daotian Evidence-Based Technology Co., Ltd, Shanghai, China.
- Medical Affairs, Pharmaceuticals, Bayer Healthcare Company Ltd., Beijing, China.
- Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, China. yan2128ts@med.nwu.edu.cn.
Förderung
- Bayer Healthcare Company Ltd., Beijing, China
Zitieren
APA
Wu, J., He, X., Qi, F., Zhao, Z., Xu, Z., & Yan, H. (2024). Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. Ophthalmology and Therapy, 13(5), 1255-1269. https://doi.org/10.1007/s40123-024-00915-0
Vancouver
Wu J, He X, Qi F, Zhao Z, Xu Z, Yan H. Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. Ophthalmology and Therapy. 2024;13(5):1255-1269. doi:10.1007/s40123-024-00915-0
BibTeX
@article{Wu2024,
author = {Wu, Jing and He, Xiaoning and Qi, Fang and Zhao, Zhan and Xu, Zhe and Yan, Hong},
title = {Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis},
journal = {Ophthalmology and Therapy},
year = {2024},
volume = {13},
number = {5},
pages = {1255--1269},
doi = {10.1007/s40123-024-00915-0}
}
EUVIMED